COMMUNIQUÉS West-GlobeNewswire

TerrAscend Reports Second Quarter 2026 Financial Results
06/08/2026
Q2 2026 Net Revenue of $67.1 Million, Up Sequentially and Year-Over-Year Q2 2026 Gross Profit Margin of 54.0%, Up 120 Basis Points Sequentially and 290 Basis Points Year-Over-Year Q2 2026 Net Cash Provided from [...]
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
06/08/2026
- Duchenne (SGT-003): SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with 53 participants dosed as of August 4, 2026 - - Solid expects to meet with the FDA in late Q4 2026 to [...]
Oculis Reports Q2 2026 Financial Results and Provides Company Update
06/08/2026
ZUG, Switzerland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential [...]
Oculis Reports Q2 2026 Financial Results and Provides Company Update
06/08/2026
Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential in acute multiple sclerosis (MS) relapses following [...]
CVRx Reports Second Quarter 2026 Financial and Operating Results
06/08/2026
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results
06/08/2026
Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segment Successful limited launch of the power liposuction handpiece for the AYON platform [...]
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
06/08/2026
Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026 Initiated Phase 2b [...]
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
06/08/2026
Planned IND submission for SZN-8141 in diabetic macular edema by the end of the third quarter of 2026 Expect to initiate SZN-8141 Phase 1b/2a study, DUET, by year-end 2026 with initial data anticipated in the second [...]
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
06/08/2026
Selected z ovegalisib plus atirmociclib as go-forward triplet regimen for 1L breast cancer; Phase 3 1L trial in endocrine - sensitive patients expected to initiate in early 2027, subject to regulatory feedback Presented [...]
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
06/08/2026
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
06/08/2026
Conference Call Scheduled for Friday, August 14, 2026 at 9:00 AM ET PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics [...]
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
06/08/2026
CANTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, [...]
Maxim Hair Restoration Earns LegitScript Certification, Reinforcing Its Position as a Leading Hair Transplant Clinic
06/08/2026
Certification underscores Maxim's commitment to ethical and transparent practices in hair restoration services. New York City, NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration , a 15-location [...]
MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium
06/08/2026
First patients treated with agenT-797 were alive and afebrile at endpoint Day 28 with improved oxygenation, infection control and removal from ventilator and vasopressor support Analysis of blood and lung fluid showed [...]
Chemed Corporation Declares Quarterly Dividend of 70 Cents
06/08/2026
CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE ) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company’s capital stock, [...]
Genmab Announces Financial Results for the First Half of 2026
06/08/2026
August 6, 2026 Copenhagen, Denmark; Interim Report for the Six Months Ended June 30, 2026 Highlights Genmab announced positive Phase 3 results for epcoritamab plus lenalidomide in patients with relapsed/refractory [...]
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
06/08/2026
Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) ( [...]
ASHA To Present Its Annie Glenn Award To The Pitt
06/08/2026
TV Medical Drama Spotlights the Importance of Effective Communication Rockville, MD, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The Pitt , a popular and highly regarded TV series, will receive the American Speech-Language- [...]
Kymanox Launches AI-Enabled Quality and Regulatory Capabilities for Life Sciences Organizations
06/08/2026
Built on a foundation of responsible artificial intelligence (AI) use with expert-verified deliverables, Kymanox can now apply AI to Quality Management System (QMS) development, batch release report review, and human [...]

Pages